Mandate

Vinge advises Canadian Plasman Group and its owner Insight Equity on its acquisition of Plastal Industri AB.

May 30, 2016

Plastal Industri is a leading supplier of engineered thermoplastic bumper modules, painted and unpainted exterior trim and plastic parts serving both the passenger car and heavy commercial vehicle markets. The company operates out of four state-of-the-art production facilities in Sweden, Norway, and Belgium.

The Plasman Group is a designer and manufacturer of plastic injection molding for state-of-the-art automated painting and complete assembly operations of Class “A” exterior trim products and sub-systems to a variety of OEM and Tier 1 customers. The company offers fully-integrated design, engineering, tooling, molding, finishing (painting and chroming), and assembly capabilities and has approximately 3,600 employees across its network of 16 facilities across North America and Europe.

The Vinge team advising Plasman Group includes partner Fredrik Sonander, associates Amanda Winberg, Hampus Wikerstål and Frida Bäckegren and paralegals Camilla Andersson and Karl-Manne Johnsson. Partner Anna Palmerus provided competition law advice.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025